Kyung Dong Pharmaceutical Co (XKRX:011040) Long-Term Capital Lease Obligation : ₩15 Mil (As of Mar. 2024)

View and export this data going back to 1992. Start your Free Trial

What is Kyung Dong Pharmaceutical Co Long-Term Capital Lease Obligation?

Kyung Dong Pharmaceutical Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩15 Mil.

Kyung Dong Pharmaceutical Co's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (₩166 Mil) to Dec. 2023 (₩81 Mil) and declined from Dec. 2023 (₩81 Mil) to Mar. 2024 (₩15 Mil).

Kyung Dong Pharmaceutical Co's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (₩2,686 Mil) to Dec. 2022 (₩1,434 Mil) and declined from Dec. 2022 (₩1,434 Mil) to Dec. 2023 (₩81 Mil).

Kyung Dong Pharmaceutical Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Kyung Dong Pharmaceutical Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyung Dong Pharmaceutical Co Long-Term Capital Lease Obligation Chart

Kyung Dong Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

717.18

420.56

2,686.16

1,434.13

81.08

Kyung Dong Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															368.11	271.08	165.81	81.08	14.91

Kyung Dong Pharmaceutical Co (XKRX:011040) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Kyung Dong Pharmaceutical Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Kyung Dong Pharmaceutical Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Kyung Dong Pharmaceutical Co (XKRX:011040) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyung Dong Pharmaceutical Co Ltd (XKRX:011040) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

N/A

Address

1926, Nambusunhwan-ro, Gwanak-gu, Seoul, KOR

Website

http://www.kdpharma.co.kr

Kyung Dong Pharmaceutical Co Ltd is a South Korea-based company engaged in the manufacturing and marketing of pharmaceutical products. Its products include liver therapies, gastrointestinal drugs, antimigraine drugs, antiviral, anti-obesity medications, antibacterial drugs, antidiabetic drugs, antifungal, vitamins, as well as drugs for osteoporosis, cardiovascular, muscle relaxant, neuropathic and other diseases.

Kyung Dong Pharmaceutical Co (XKRX:011040) Headlines

No Headlines